4//SEC Filing
Giuffre Randall Michael 4
Accession 0001235802-24-000044
CIK 0001401040other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:02 PM ET
Size
8.2 KB
Accession
0001235802-24-000044
Insider Transaction Report
Form 4
Giuffre Randall Michael
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-01+28,472→ 28,472 totalExercise: $2.90Exp: 2034-05-31→ Common Shares (28,472 underlying)
Holdings
- 21,070(indirect: By Spouse)
Voting Common Shares, no par value per share
- 364,551
Voting Common Shares, no par value per share
- 25,573(indirect: See footnote)
Voting Common Shares, no par value per share
Footnotes (3)
- [F1]Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 84,155 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 111,360 voting common shares held by Michael Giuffre individually.
- [F2]These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.
- [F3]Vests in four nearly equal quarterly installments over one year.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001759822
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:02 PM ET
- Size
- 8.2 KB